Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TRANSPOSON SYSTEM AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/061314
Kind Code:
A1
Abstract:
Provided is a transposon system, comprising a transposase and a transposon. The transposase is a mutant transposase or a fusion transposase. Compared with a wild-type ZB transposase as shown by SEQ ID NO: 1, the mutant transposase has one or more amino acid substitution mutations and has improved transposition efficiency. The transposon contains a mutant ITR sequence, which lacks a CpG motif compared with a wild-type ITR sequence SEQ ID NO: 11 or 12, and can reduce immunogenicity without affecting the transposition efficiency.

Inventors:
ZHANG PINGJING (CN)
LIU TAO (CN)
SONG CHENGYI (CN)
GAO BO (CN)
SUN YAN (CN)
QIAN QIJUN (CN)
Application Number:
PCT/CN2023/120383
Publication Date:
March 28, 2024
Filing Date:
September 21, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MAXIRNA SHANGHAI PHARMACEUTICAL CO LTD (CN)
MAXIRNA ZHEJIANG TECH CO LTD (CN)
SHANGHAI CELL THERAPY GROUP CO LTD (CN)
International Classes:
C12N15/85; C12N5/10; C12N9/12; C12N15/54
Domestic Patent References:
WO2010085699A22010-07-29
WO2022118237A12022-06-09
Foreign References:
CN112159822A2021-01-01
CN105018523A2015-11-04
US20020016975A12002-02-07
Other References:
DATABASE UniProtKB 5 December 2018 (2018-12-05), "Transposase Tc1-like domain-containing protein {ECO:0008006|Google:ProtNLM}; OS Pundamilia nyererei", XP093148747, retrieved from UniProt Database accession no. A0A3B4G800
TOBIAS JURSCH;CSABA MISKEY;ZSUZSANNA IZSVÁK;ZOLTÁN IVICS : "Regulation of DNA transposition by CpG methylation and chromatin structure in human cells", MOBILE DNA, BIOMED CENTRAL LTD, LONDON, UK, vol. 4, no. 1, 15 May 2013 (2013-05-15), London, UK , pages 15, XP021152734, ISSN: 1759-8753, DOI: 10.1186/1759-8753-4-15
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: